Human IGFBP-3 Quantikine PharmPak (50 Plates)

• Supplier: R&D Systems
• Catalog: PDGB300
• Category: ELISA Kit
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (100 µL), Serum (10 µL), EDTA Plasma (10 µL), Heparin Plasma (10 µL)
• Sensitivity: 0.14 ng/mL
• Range: 0.781 - 50 ng/mL (Serum, Heparin Plasma, Cell Culture Supernates, EDTA Plasma)
• Format: 96-well strip plate
• Description: The Quantikine Human IGFBP-3 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human IGFBP-3 in cell culture supernates, serum, and plasma
• Gene: IGFBP3

Product References

Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells - Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells

Choi YJ, Park GM, Rho JK, Kim SY, So GS, Kim HR, Choi CM, Lee JC. PLoS One. 2013 Dec 5;8(12):e81393.

Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic - Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic

Higgins MF, Russell NE, Crossey PA, Nyhan KC, Brazil DP, McAuliffe FM. PLoS One. 2012;7(2):e29164.

Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth - Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth

Weimer A, Madry H, Venkatesan JK, Schmitt G, Frisch J, Wezel A, Jung J, Kohn D, Terwilliger EF, Trippel SB, Cucchiarini M. Mol Med. 2012 May 9;18:346-58.

FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth - FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth

Imamura Y, Sakamoto S, Endo T, Utsumi T, Fuse M, Suyama T, Kawamura K, Imamoto T, Yano K, Uzawa K, Nihei N, Suzuki H, Mizokami A, Ueda T, Seki N, Tanzawa H, Ichikawa T. PLoS One. 2012;7(8):e42456.

Administration of omega-3 fatty acids and Raloxifene to women at high risk of - Administration of omega-3 fatty acids and Raloxifene to women at high risk of

Signori C, DuBrock C, Richie JP, Prokopczyk B, Demers LM, Hamilton C, Hartman TJ, Liao J, El-Bayoumy K, Manni A. Eur J Clin Nutr. 2012 Aug;66(8):878-84.

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 - Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3

Elzi DJ, Lai Y, Song M, Hakala K, Weintraub ST, Shiio Y. Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12052-7. doi:

The stature of boys is inversely correlated to the levels of their sertoli cell - The stature of boys is inversely correlated to the levels of their sertoli cell

Morgan K, Dennis NA, Ruffman T, Bilkey DK, McLennan IS. PLoS One. 2011;6(6):e20533.

Prognostic significance of angiogenic factors in uterine cervical cancer. - Prognostic significance of angiogenic factors in uterine cervical cancer.

Landt S, Wehling M, Heidecke H, Jeschke S, Korlach S, Stoblen F, Schmid P, Blohmer JU, Lichtenegger W, Sehouli J, Kummel S. Anticancer Res. 2011 Aug;31(8):2589-95.

Abnormalities in metalloproteinase pathways and IGF-I axis: a link between birth - Abnormalities in metalloproteinase pathways and IGF-I axis: a link between birth

Sesso R, Franco MC. Am J Hypertens. 2010 Jan;23(1):6-11.

Biological effects induced by insulin-like growth factor binding protein 3 - Biological effects induced by insulin-like growth factor binding protein 3

Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Florenes VA. Int J Cancer. 2010 Jan 15;126(2):350-61.